Procyon Corporation cash flow statement PCYN

Annual Quarterly

In fiscal 2024, which ended Jun 30, 2024, Procyon Corporation used $61,251 of cash from operations, down 142.1% from the year before. It spent $63,912 on capital expenditures. Free cash flow was negative, at -$125,163.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021	FY 2020 Jun 30, 2020	FY 2019 Jun 30, 2019	FY 2018 Jun 30, 2018	FY 2017 Jun 30, 2017	FY 2016 Jun 30, 2016	FY 2015 Jun 30, 2015
Operating
Depreciation and amortization	0 +54.7%	0 +38.2%	0 -11.8%	0 -19.7%	0 +2.5%	0 +10.0%	0 +4.8%	0 +21.2%	0 +5.1%	0 +9.4%
Stock-based compensation	—	0	0 -100.0%	0	—	—	—	0 -7.7%	0 +875.3%	0 -14.0%
Operating cash flow	-0 -142.1%	0 +137.9%	-0 -237.2%	0 +40.6%	0 +291.0%	0 -41.2%	0 -56.7%	0 +968.2%	0 +104.8%	-0 -118.4%
Investing
Capital expenditures	0 -64.5%	0 +118.0%	0 +26.8%	0 +182.8%	0 -19.9%	0 -38.5%	0 +147.8%	0 -74.3%	0 +10.1%	0 +536.1%
Investing cash flow	-0 +85.9%	-0 -450.0%	-0 -117.2%	0 +2082.0%	-0 +15.7%	-0 -299.3%	0 -66.6%	0 +120.9%	-0 -211.3%	-0 -536.1%
Financing
Debt issued	—	—	0 -100.0%	—	0	—	—	—	—	—
Financing cash flow	0	0	0 +100.0%	-0 -199.0%	0 +9626.1%	-0 +44.3%	-0 +97.1%	-0 -397.3%	0 -45.8%	0 +173.8%
Change in cash
Net change in cash	-0 +59.5%	-0 +33.7%	-0 -183.1%	1 +49.3%	0	—	—	—	—	—
Free cash flow	-0 -261.0%	-0 +92.6%	-0 -317.5%	0 +22.0%	0 +695.7%	0 -44.5%	0 -78.0%	0 +431.0%	-0 +88.1%	-0 -141.4%
Per share
Free cash flow per share	-0.02 -259.5%	-0.00 +92.6%	-0.06 -323.7%	0.03 +22.0%	0.02 +695.7%	0.00 -46.1%	0.00 -77.4%	0.02 +430.0%	-0.01 +88.4%	-0.06 -147.2%
Ratios
Free cash flow margin	-2.51%	-0.74%	-9.63%	4.54%	4.05%	0.53%	0.99%	4.50%	-1.58%	-16.54%
Capital expenditures to revenue	1.28%	3.84%	1.71%	1.38%	0.53%	0.69%	1.16%	0.47%	2.12%	2.40%
Stock-based compensation to revenue	—	0.00%	0.00%	0.42%	—	—	—	0.12%	0.15%	0.02%
Cash conversion	—	—	—	0.40x	1.78x	1.87x	—	16.12x	0.17x	-16.61x

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: PCYN (OTC)
Fiscal year ends: June 30
Incorporated in: CO
Headquarters: Clearwater, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 812306

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.